(Q51608906)

8 April 2018

reason for preferred rank

title

Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

28 October 2022

Effect of an oral alpha 2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682787

28 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

28 October 2022

author name string

Ortiz-Alonso FJ

1

1 reference

8 April 2018

F. J. Ortiz-Alonso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682787

28 October 2022

W. H. Herman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682787

28 October 2022

B. J. Gertz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682787

28 October 2022

V. C. Williams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682787

28 October 2022

M. J. Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682787

28 October 2022

J. B. Halter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682787

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682787

28 October 2022

publication date

1 November 1991

1 reference

8 April 2018

full work available at URL

number of pages

8

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:002604959190210N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

https://api.elsevier.com/content/article/PII:002604959190210N?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

28 October 2022

1 reference

8 April 2018

volume

40

1 reference

8 April 2018

issue

11

1 reference

8 April 2018

page(s)

1160-1167

1 reference

8 April 2018

Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mouse.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Adrenergic mechanisms in the hyperglycaemia and hyperinsulinaemia of diabetic KK mice.

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Effects of alpha-adrenoceptor antagonists on clonidine-induced inhibition of insulin secretion by isolated pancreatic islets

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743.

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Clinical evaluation of a benzofuroquinolizine alpha 2-adrenoceptor antagonist.

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Failure of sulfonylureas to suppress plasma glucagon in man

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

The alpha adrenoceptor antagonist properties of idazoxan in normal subjects

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0026-0495(91)90210-N

28 October 2022

Identifiers

1 reference

8 April 2018

1 reference

8 April 2018